Zacks Equity Research believes now is a good time to be an investor in the US fishing and marine ingredients firm

By Tom Seaman

Skretting margins have taken a hit from Marine Harvest’s expansion into feed, but this does not mean the Nutreco-owned firm is going to back off on R&D spend

Salmon byproducts firm slides further into the red in Q2, yet flags up ‘key agreements’ with firms in Japan, China

By Tom Seaman

Undercurrent News is in Trondheim, Norway reporting live this week 

By Tom Seaman

Feed for shrimp, tilapia and other warmwater species in Asia, Africa and Latin America could make up well over half of Skretting’s business in ten years' time, says top exec

By Tom Seaman

Banker sees the prospect of vertical integration in less consolidated species than salmon, such as shrimp and tilapia, as more attractive for US agribusiness giant

By Tom Seaman

High price is justified due to benefits Cargill can get from bringing technology and knowledge Ewos has in salmon to warmwater species, such as shrimp and tilapia

By Tom Seaman

After paying a very high price for Ewos, analysts feel a move downstream into farming is one way Cargill may look to get long-term value

By Tom Seaman

Norwegian banker who left Arctic Securities last year has moved to New York to manage private equity eyeing ‘up and mid-stream’ investments in seafood

By Jason Smith

Two groups of investors who hold nearly 14% of the shares in Texas-based menhaden catcher and processor Omega Protein are openly advocating for the sale of the company, as they believe the shares are currently undervalued